Literature DB >> 16248889

Knock-down of POSH expression is neuroprotective through down-regulating activation of the MLK3-MKK4-JNK pathway following cerebral ischaemia in the rat hippocampal CA1 subfield.

Quan-Guang Zhang1, Rui-Min Wang, Xiao-Hui Yin, Jing Pan, Tian-Le Xu, Guang-Yi Zhang.   

Abstract

We investigated the expression and subcellular localization of the multidomain protein POSH (plenty of SH3s) by immunohistochemistry and western blot analysis, as well as its role in the selective activation of mixed-lineage kinases (MLKs) 3, MAP kinase kinase (MKK) 4, c-Jun N-terminal kinases (JNKs) and the c-Jun signalling cascade in the rat hippocampal CA1 region following cerebral ischaemia. Our results indicated that the cytosol immunoreactivity of POSH was strong in the CA1-CA3 pyramidal cell but weak in the DG granule cell of the rat hippocampus both in sham control and after reperfusion. Co-immunoprecipitation experiments showed that the interactions of MLK3, MKK4 and phospho-JNKs with POSH were persistently enhanced during the early (30 min) and the later reperfusion period (from 1 to 3 days) compared with sham controls. Consistently, MLK3-MKK4-JNK activation was rapidly increased with peaks both at 30 min and 3 days of reperfusion. Intracerebroventricular infusion of POSH antisense oligodeoxynucleotides (AS-ODNs) not only significantly reduced the protein level of POSH, markedly decreased its interactions with MLK3, MKK4 and phospho-JNKs, but also attenuated the activation of the JNK signalling pathway. In addition, infusion of POSH AS-ODNs significantly increased the neuronal density in the CA1 region at 5 days of reperfusion. Our results suggest that POSH might serve as a scaffold mediating JNK signalling activation in the hippocampal CA1 region following cerebral ischaemia, and POSH AS-ODNs exerts its protective effects on ischaemic injury through a mechanism of inhibition of the MLK3-MKK4-JNK signalling pathway, involving c-Jun and caspase 3 activation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16248889     DOI: 10.1111/j.1471-4159.2005.03435.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  15 in total

Review 1.  The inflammatory response in stroke.

Authors:  Qing Wang; Xian Nan Tang; Midori A Yenari
Journal:  J Neuroimmunol       Date:  2006-12-26       Impact factor: 3.478

Review 2.  Inflammatory responses in brain ischemia.

Authors:  Masahito Kawabori; Midori A Yenari
Journal:  Curr Med Chem       Date:  2015       Impact factor: 4.530

3.  Sh3rf2/POSHER protein promotes cell survival by ring-mediated proteasomal degradation of the c-Jun N-terminal kinase scaffold POSH (Plenty of SH3s) protein.

Authors:  Michael Wilhelm; Nickolay V Kukekov; Travis L Schmit; Katherine V Biagas; Andrew A Sproul; Stephen Gire; Margaret E Maes; Zhiheng Xu; Lloyd A Greene
Journal:  J Biol Chem       Date:  2011-11-28       Impact factor: 5.157

4.  Neuroprotection against transient focal cerebral ischemia and oxygen-glucose deprivation by interference with GluR6-PSD95 protein interaction.

Authors:  Chang-Zhou Yu; Chong Li; Dong-Sheng Pei; Yan-Yan Zong; Qiong Shi; Xiang-Ru Wen; Qiu-Hua Guan; Dong Hang; Xiao-Yu Hou; Guang-Yi Zhang
Journal:  Neurochem Res       Date:  2009-05-18       Impact factor: 3.996

5.  Cardiac macrophage migration inhibitory factor inhibits JNK pathway activation and injury during ischemia/reperfusion.

Authors:  Dake Qi; Xiaoyue Hu; Xiaohong Wu; Melanie Merk; Lin Leng; Richard Bucala; Lawrence H Young
Journal:  J Clin Invest       Date:  2009-11-16       Impact factor: 14.808

6.  Preconditioning neuroprotection in global cerebral ischemia involves NMDA receptor-mediated ERK-JNK3 crosstalk.

Authors:  Quan-Guang Zhang; Rui-Min Wang; Dong Han; Li-Cai Yang; Jie Li; Darrell W Brann
Journal:  Neurosci Res       Date:  2009-03       Impact factor: 3.304

7.  Role of Rac1 GTPase in JNK signaling and delayed neuronal cell death following global cerebral ischemia.

Authors:  Quan-Guang Zhang; Ruimin Wang; Dong Han; Yan Dong; Darrell W Brann
Journal:  Brain Res       Date:  2009-01-30       Impact factor: 3.252

Review 8.  Adjunctive and long-acting nanoformulated antiretroviral therapies for HIV-associated neurocognitive disorders.

Authors:  Howard E Gendelman; Harris A Gelbard
Journal:  Curr Opin HIV AIDS       Date:  2014-11       Impact factor: 4.283

Review 9.  Innate inflammatory responses in stroke: mechanisms and potential therapeutic targets.

Authors:  J Y Kim; M Kawabori; M A Yenari
Journal:  Curr Med Chem       Date:  2014       Impact factor: 4.530

10.  A transmissible cytotoxic activity isolated from a patient with brain ischemia causes microglial cell activation and dysfunction.

Authors:  F Beretti; V Cenacchi; M Portolani; A Ardizzoni; E Blasi; C Cermelli
Journal:  Cell Mol Neurobiol       Date:  2007-03-23       Impact factor: 4.231

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.